ABT vs AP · P/E 25, rev $44.33B vs rev $418.3M
Abbott Laboratories (ABT) versus Ampco-Pittsburgh Corporation (AP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Ampco-Pittsburgh Corporation (AP) is a metal fabrication company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported AP revenue for 2024-12-31 was $418.3M. Net income was $2.4M. Revenue was down 1.0% from 2023-12-31 to 2024-12-31. AP currently screens at market cap $221.2M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. AP currently screens at market cap $221.2M.
Not investment advice. Open the ABT and AP stock pages for the full models.
Not investment advice.